Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations

Cancer Letters

Volumn 274, Issue 2, 2009, Pages 266-270

  Tricarico, Rossella ^a   Bet, Paola ^b   Ciambotti, Benedetta ^a   Di Gregorio, Carmela ^c   Gatteschi, Beatrice ^b   Gismondi, Viviana ^b   Toschi, Benedetta ^a   Tonelli, Francesco ^a   Varesco, Liliana ^b   Genuardi, Maurizio ^a,d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Carpi Hospital   (Italy)

^d Fiorgen Foundation for Pharmacogenomics   (Italy)

Author keywords

Base excision repair; Colorectal cancer; Lynch syndrome; MAP; Polyposis

Indexed keywords

ADULT; ARTICLE; DNA SEQUENCE; ENDOMETRIUM CANCER; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION;

ALLELES; DNA GLYCOSYLASES; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, RAS; HUMANS; MIDDLE AGED; MUTATION;

EID: 58149308483     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.022     Document Type: Article

References (41)

1. Al-Tassan N., Chmiel N.H., Maynard J., Fleming N., Livingston A.L., Williams G.T., Hodges A.K., Davies D.R., David S.S., Sampson J.R., and Cheadle J.P. Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat. Genet. 30 (2002) 227-232
2. Lipton L., Halford S.E., Johnson V., Novelli M.R., Jones A., Cummings C., Barclay E., Sieber O., Sadat A., Bisgaard M.L., Hodgson S.V., Aaltonen L.A., Thomas H.J., and Tomlinson I.P. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 63 (2003) 7595-7599
3. Sampson J.R., Dolwani S., Jones S., Eccles D., Ellis A., Evans D.G., Frayling I., Jordan S., Maher E.R., Mak T., Maynard J., Pigatto F., Shaw J., and Cheadle J.P. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362 (2003) 39-41
4. Sieber O.M., Lipton L., Crabtree M., Heinimann K., Fidalgo P., Phillips R.K., Bisgaard M.L., Orntoft T.F., Aaltonen L.A., Hodgson S.V., Thomas H.J., and Tomlinson I.P. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N. Engl. J. Med. 348 (2003) 791-799
5. Gismondi V., Meta M., Bonelli L., Radice P., Sala P., Bertario L., Viel A., Fornasarig M., Arrigoni A., Gentile M., Ponz de Leon M., Anselmi L., Mareni C., Bruzzi P., and Varesco L. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int. J. Cancer 109 (2004) 680-684
6. Nielsen M., Poley J.W., Verhoef S., Van Puijenbroek M., Weiss M.M., Burger G.T., Dommering C.J., Vasen H.F., Kuipers E.J., Wagner A., Morreau H., and Hes F.J. Duodenal carcinoma in MUTYH-associated polyposis. J. Clin. Pathol. 59 (2006) 1212-1215
7. Baglioni S., Melean G., Gensini F., Santucci M., Scatizzi M., Papi L., and Genuardi M. A kindred with MYH-associated polyposis and pilomatricomas. Am. J. Med. Genet. A 134 (2005) 212-214
8. Nielsen M., Franken P.F., Reinards T.H., Weiss M.M., Wagner A., Van der Klift H., Kloosterman S., Houwing-Duistermaat J.J., Aalfs C.M., Ausems M.G., Bröcker-Vriends A.H., Gomez Garcia E.B., Hoogerbrugge N., Menko F.H., Sijmons R.H., Verhoef S., Kuipers E.J., Morreau H., Breuning M.H., Tops C.M., Wijnen J.T., Vasen H.F., Fodde R., and Hes F.J. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J. Med. Genet. 42 (2005) e54
9. Ponti G., Ponz M., de Leon S., Maffei M., Pedroni L., Losi C., Di Gregorio V., Gismondi A., Scarselli P., Benatti B., Roncari S., Seidenari G., Pellacani C., Varotti E., Prete L., Varesco L., and Roncucci L. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin. Genet. 68 (2005) 442-447
10. Aretz S., Uhlhaas S., Goergens H., Siberg K., Vogel M., Pagenstecher C., Mangold E., Caspari R., Propping P., and Friedl W. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int. J. Cancer 119 (2006) 807-814
11. Barnetson R.A., Devlin L., Miller J., Farrington S.M., Slater S., Drake A.C., Campbell H., Dunlop M.G., and Porteous M.E. Germline mutation prevalence in the base excision repair gene, MYH, in patients with endometrial cancer. Clin. Genet. 72 (2007) 551-555
12. Merg A., and Howe J.R. Genetic conditions associated with intestinal juvenile polyps. Am. J. Med. Genet. C Semin. Med. Genet. 129 (2004) 44-55
13. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, S.J. Meltzer, M.A. Rodriguez-Bigas, R. Fodde, G.N. Ranzani, S. Srivastava, A National Cancer Institute Workshop on Microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res. 58 (1998) 5248-5257.
14. Pedroni M., Sala E., Scarselli A., Borghi F., Menigatti M., Benatti P., Percesepe A., Rossi G., Foroni M., Losi L., Di Gregorio C., De Pol A., Nascimbeni R., Di Betta E., Salerni B., de Leon M.P., and Roncucci L. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res. 61 (2001) 896-899
15. Willmore-Payne C., Holden J.A., Tripp S., and Layfield L.J. Human malignant melanoma: detection of BRAF-and c-kit-activating mutations by high-resolution amplicon melting analysis. Hum. Pathol. 36 (2005) 486-493
16. Simi L., Pratesi N., Vignoli M., Sestini R., Cianchi F., Valanzano R., Nobili S., Mini E., Pazzagli M., and Orlando C. High resolution melting analysis for rapid detection of KRAS, BRAF and PIK3CA gene mutations in colorectal cancer. Am. J. Clin. Pathol. 130 (2008) 247-253
17. Marchese R., Muleti A., Brozzetti S., Gandini O., Brunetti E., and French D. Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer. Br. J. Cancer 90 (2004) 2243
18. Lucci-Cordisco E., Zito I., Gensini F., and Genuardi M. Hereditary nonpolyposis colorectal cancer and related conditions. Am. J. Med. Genet. A 122 (2003) 325-334
19. Machin P., Catasus L., Pons C., Muñoz J., Matias-Guiu X., and Prat J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum. Pathol. 33 (2002) 206-212
20. Samuels Y., and Velculescu V.E. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3 (2004) 1221-1224
21. Pappa K.I., Choleza M., Markaki S., Giannikaki E., Kyroudi A., Vlachos G., Voulgaris Z., and Anagnou N.P. Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status. Gynecol. Oncol. 100 (2006) 596-600
22. Prat J., Gallardo A., Cuatrecasas M., and Catasús L. Endometrial carcinoma: pathology and genetics. Pathology 39 (2007) 72-87
23. Catasus L., Gallardo A., Cuatrecasas M., and Prat J. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters. Mod. Pathol. 21 (2008) 131-139
24. Jones S., Lambert S., Williams G.T., Best J.M., Sampson J.R., and Cheadle J.P. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Br. J. Cancer 90 (2004) 1591-1593
25. Andreyev H.J., Norman A.R., Cunningham D., Oates J.R., and Clarke P.A. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study. J. Natl. Cancer Inst. 90 (1998) 675-684
26. van Puijenbroek M., Nielsen M., Tops C.M., Halfwerk H., Vasen H.F., Weiss M.M., van Wezel T., Hes F.J., and Morreau H. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G>T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin. Cancer Res. 14 (2008) 139-142
27. Enomoto T., Inoue M., Perantoni A.O., Buzard G.S., Miki H., Tanizawa O., and Rice J.M. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Cancer Res. 51 (1991) 5308-5314
28. Mizuuchi H., Nasim S., Kudo R., Silverberg S.G., Greenhouse S., and Garrett C.T. Clinical implications of K-ras mutations in malignant epithelial tumours of the endometrium. Cancer Res. 52 (1992) 2777-2781
29. Fujimoto I., Shimizu Y., Hirai Y., Chen J.T., Teshima H., Hasumi K., Masubuchi K., and Takahashi M. Studies on ras oncogene activation in endometrial carcinoma. Gynecol. Oncol. 48 (1993) 196-202
30. Sasaki H., Nishii H., Takahashi H., Tada A., Furusato M., Terashima Y., Siegal G.P., Parker S.L., Kohler M.F., Berchuck A., et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res. 53 (1993) 1906-1910
31. Duggan B.D., Felix J.C., Muderspach L.I., Tsao J.L., and Shibata D.K. Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. Cancer Res. 54 (1994) 1604-1607
32. Caduff R.F., Johnston C.M., and Frank T.S. Mutations of the Ki-ras oncogene in carcinoma of the endometrium. Am. J. Pathol. 146 (1995) 182-188
33. Ito K., Watanabe K., Nasim S., Sasano H., Sato S., Yajima A., Silverberg S.G., and Garrett C.T. K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient. Gynecol. Oncol. 63 (1996) 238-246
34. Esteller M., García A., Martínez-Palones J.M., Xercavins J., and Reventós J. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer. Eur. J. Cancer 33 (1997) 1572-1577
35. Mutter G.L., Wada H., Faquin W.C., and Enomoto T. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol. Pathol. 52 (1999) 257-262
36. Pijnenborg J.M., Dam-de Veen G.C., Kisters N., Delvoux B., van Engeland M., Herman J.G., and Groothuis P.G. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer. Ann. Oncol. 18 (2007) 491-497
37. Forbes S., Clements J., Dawson E., Bamford S., Webb T., Dogan A., Flanagan A., Teague J., Wooster R., Futreal P.A., and Stratton M.R. COSMIC 2005. Br. J. Cancer 94 (2006) 318-322
38. Feng Y.Z., Shiozawa T., Miyamoto T., Kashima H., Kurai M., Suzuki A., and Konishi I. BRAF mutation in endometrial carcinoma and hyperplasia: correlation with KRAS and p53 mutations and mismatch repair protein expression. Clin. Cancer Res. 11 (2005) 6133-6138
39. Velasco A., Bussaglia E., Pallares J., Dolcet X., Llobet D., Encinas M., Llecha N., Palacios J., Prat J., and Matias-Guiu X. PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations. Hum. Pathol. 37 (2006) 1465-1472
40. Oliveira C., Velho S., Moutinho C., Ferreira A., Preto A., Domingo E., Capelinha A.F., Duval A., Hamelin R., Machado J.C., Schwartz Jr. S., Carneiro F., and Seruca R. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26 (2007) 158-163
41. Kang S., Seo S.S., Chang H.J., Yoo C.W., Park S.Y., and Dong S.M. Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma. Int. J. Gynecol. Cancer 9999 (2008)